Laboratory-based Hypnosis Intervention on Pain Responsivity in Adolescents With Sickle Cell Disease

Completed · Not applicable

Conditions studied: Sickle Cell Disease

In brief

The purpose of this study is to test the effects of a laboratory-based hypnosis session compared to an attention control condition on peripheral blood flow, autonomic stress responses, and acute pain responses in adolescents (ages 12-21) with sickle cell disease, and examine how perceived disease-related stigma may affect these responses.

Key facts

Study ID

NCT02987725

Run by

University of California, Los Angeles

People needed

25

Starts

2018-03-16

Expected to finish

2020-11-01

Last updated by the study team

2020-11-04

Who can join

Age: 12 and older, up to 21. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• A diagnosis of sickle cell disease
• Age 12-21 years old
• Fluent in English (the intervention will be delivered in English)
• Participant is cognitively able to provide informed signed consent or assent
• Participant is cognitively able to follow instructions

You may not qualify if…

• Under 12 years of age or over 21 years of age
• Not fluent in English
• Pain medication prescription has changed or if they have been hospitalized for a vaso-occlusive episode within 30 days of study participation.
• Diagnosis of a condition (e.g., neurological disorder affecting peripheral sensation, skin abnormality over the stimulus site, obstructive sleep apnea, diabetes, ischemic heart disease) or cognitive impairment that may affect data integrity or the ability to complete study procedures.

Where it is running

• University of California, Los Angeles — Los Angeles, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.